|
|
| | MK 0343 Basic information |
| Product Name: | MK 0343 | | Synonyms: | MK 0343;1,2,4-Triazolo[4,3-b]pyridazine, 7-cyclobutyl-3-(2,6-difluorophenyl)-6-[(1-Methyl-1H-1,2,4-triazol-5-yl)Methoxy]-;7-Cyclobutyl-3-(2,6-difluorophenyl)-6-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]-1,2,4-triazolo[4,3-b]pyridazine;MRK-409;MK-0343 >=98% (HPLC);7-Cyclobutyl-3-(2,6-difluorophenyl)-6-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]-1,2,4-triazo[4,3-b]pyridazine;MK0343,MK 0343 | | CAS: | 233275-76-8 | | MF: | C19H17F2N7O | | MW: | 397.38 | | EINECS: | | | Product Categories: | | | Mol File: | 233275-76-8.mol |  |
| | MK 0343 Chemical Properties |
| density | 1.57±0.1 g/cm3(Predicted) | | storage temp. | Inert atmosphere,2-8°C | | solubility | DMSO: soluble10mg/mL, clear | | pka | 2.11±0.10(Predicted) | | form | powder | | color | white to beige |
| | MK 0343 Usage And Synthesis |
| Uses | MK 0343 is a subtype-selective partial GABAA receptor agonist with the ability to cause anxiolytic and non-sedating properties. |
| | MK 0343 Preparation Products And Raw materials |
|